Successful Bone Marrow Transplantation in a Patient with Acute Myeloid Leukemia Developed from Severe Congenital Neutropenia Using Modified Chemotherapy and Conditioning Regimen for Leukemia
Abstract
1. Introduction
2. Case Report
3. Discussion and Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Welte, K.; Zeidler, C. Severe congenital neutropenia. Hematol. Oncol. Clin. N. Am. 2009, 23, 307–320. [Google Scholar] [CrossRef] [PubMed]
- Skokowa, J.; Dale, D.C.; Touw, I.P.; Zeidler, C.; Welte, K. Severe congenital neutropenias. Nat. Rev. Dis. Primers 2017, 3, 17032. [Google Scholar] [CrossRef]
- Makaryan, V.; Zeidler, C.; Bolyard, A.A.; Skokowa, J.; Rodger, E.; Kelley, M.L.; Boxer, L.A.; Bonilla, M.A.; Newburger, P.E.; Shimamura, A.; et al. The diversity of mutations and clinical outcomes for ELANE-associated neutropenia. Curr. Opin. Hematol. 2015, 22, 3–11. [Google Scholar] [CrossRef]
- Klein, C.; Grudzien, M.; Appaswamy, G.; Germeshausen, M.; Sandrock, I.; Schäffer, A.A.; Rathinam, C.; Boztug, K.; Schwinzer, B.; Rezaei, N.; et al. HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease). Nat. Genet. 2007, 39, 86–92. [Google Scholar] [CrossRef] [PubMed]
- Boztug, K.; Appaswamy, G.; Ashikov, A.; Schäffer, A.A.; Salzer, U.; Diestelhorst, J.; Germeshausen, M.; Brandes, G.; Lee-Gossler, J.; Noyan, F.; et al. A syndrome with congenital neutropenia and mutations in G6PC3. N. Engl. J. Med. 2009, 360, 32–43. [Google Scholar] [CrossRef] [PubMed]
- Person, R.E.; Li, F.-Q.; Duan, Z.; Benson, K.F.; Wechsler, J.; Papadaki, H.A.; Eliopoulos, G.; Kaufman, C.; Bertolone, S.J.; Nakamoto, B.; et al. Mutations in proto-oncogene GFI1 cause human neutropenia and target ELA2. Nat. Genet. 2003, 34, 308–312. [Google Scholar] [CrossRef]
- Donadieu, J.; Leblanc, T.; Bader Meunier, B.; Barkaoui, M.; Fenneteau, O.; Bertrand, Y.; Maier-Redelsperger, M.; Micheau, M.; Stephan, J.L.; Phillipe, N.; et al. Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia. Experience of the French Severe Chronic Neutropenia Study Group. Haematologica 2005, 90, 45–53. [Google Scholar]
- Rosenberg, P.S.; Alter, B.P.; Bolyard, A.A.; Bonilla, M.A.; Boxer, L.A.; Cham, B.; Fier, C.; Freedman, M.; Kannourakis, G.; Kinsey, S.; et al. The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy. Blood 2006, 107, 4628–4635. [Google Scholar] [CrossRef]
- Choi, S.W.; Boxer, L.A.; Pulsipher, M.A.; Roulston, D.; Hutchinson, R.J.; Yanik, G.A.; Cooke, K.R.; Ferrara, J.L.M.; Levine, J.E. Stem cell transplantation in patients with severe congenital neutropenia with evidence of leukemic transformation. Bone Marrow Transplant. 2005, 35, 473–477. [Google Scholar] [CrossRef] [PubMed]
- Connelly, J.A.; Choi, S.W.; Levine, J.E. Hematopoietic stem cell transplantation for severe congenital neutropenia. Curr. Opin. Hematol. 2012, 19, 44–51. [Google Scholar] [CrossRef] [PubMed]
- Zeidler, C.; Welte, K.; Barak, Y.; Barriga, F.; Bolyard, A.A.; Boxer, L.; Cornu, G.; Cowan, M.J.; Dale, D.C.; Flood, T.; et al. Stem cell transplantation in patients with severe congenital neutropenia without evidence of leukemic transformation. Blood 2000, 95, 1195–1198. [Google Scholar]
- Dale, D.C.; Bonilla, M.A.; Davis, M.W.; Nakanishi, A.M.; Hammond, W.P.; Kurtzberg, J.; Wang, W.; Jakubowski, A.; Winton, E.; Lalezari, P.; et al. A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia. Blood 1993, 81, 2496–2502. [Google Scholar] [CrossRef]
- Rosenberg, P.S.; Zeidler, C.; Bolyard, A.A.; Alter, B.P.; Bonilla, M.A.; Boxer, L.A.; Dror, Y.; Kinsey, S.; Link, D.C.; Newburger, P.E.; et al. Stable long-term risk of leukaemia in patients with severe congenital neutropenia maintained on G-CSF therapy. Br. J. Haematol. 2010, 150, 196–199. [Google Scholar] [CrossRef]
- Fioredda, F.; Iacobelli, S.; van Biezen, A.; Gasper, B.; Ancliff, P.; Donadieu, J.; Aliurf, M.; Peters, C.; Calvillo, M.; Matthes-Martin, S.; et al. Stem cell transplantation in severe congenital neutropenia: An analysis from the European Society for Blood and Marrow Transplantation. Blood 2015, 126, 1885–1892. [Google Scholar] [CrossRef] [PubMed]
- Rotulo, G.A.; Beaupain, B.; Rialland, F.; Paillard, C.; Nachit, O.; Galambrun, C.; Gandemer, V.; Bertrand, Y.; Neven, B.; Dore, E.; et al. HSCT may lower leukemia risk in ELANE neutropenia: A before-after study from the French Severe Congenital Neutropenia Registry. Bone Marrow Transplant. 2020, 55, 1614–1622. [Google Scholar] [CrossRef]
- Zeidler, C.; Nickel, A.; Sykora, K.W.; Welte, K. Improved outcome of stem cell transplantation for severe chronic neutropenia with or without secondary leukemia: A long-term analysis of European data for more than 25 years by the SCNIR. Blood 2013, 122, 3347. [Google Scholar] [CrossRef]
- Skokowa, J.; Steinemann, D.; Katsman-Kuipers, J.E.; Zeidler, C.; Klimenkova, O.; Klimiankou, M.; Ünalan, M.; Kandabarau, S.; Makaryan, V.; Beekman, R.; et al. Cooperativity of RUNX1 and CSF3R mutations in severe congenital neutropenia: A unique pathway in myeloid leukemogenesis. Blood 2014, 123, 2229–2237. [Google Scholar] [CrossRef] [PubMed]
- Setty, B.A.; Yeager, N.D.; Bajwa, R.P. Heterozygous M1V variant of ELA-2 gene mutation associated with G-CSF refractory severe congenital neutropenia. Pediatr. Blood Cancer 2011, 57, 514–515. [Google Scholar] [CrossRef]
- Hashem, H.; Abu-Arja, R.; Auletta, J.J.; Rangarajan, H.G.; Varga, E.; Rose, M.J.; Bajwa, R.P.S. Successful second hematopoietic cell transplantation in severe congenital neutropenia. Pediatr. Transplant. 2018, 22, e13078. [Google Scholar] [CrossRef] [PubMed]
- Rashidi, A.; Fisher, S.I. Spontaneous remission of acute myeloid leukemia. Leuk. Lymphoma 2015, 56, 1727–1734. [Google Scholar] [CrossRef]
- Pluchart, C.; Munzer, M.; Mauran, P.; Abély, M. Transient remission of childhood acute lymphoblastic and myeloid leukemia without any cytostatic treatment: 2 case reports and a review of literature. J. Pediatr. Hematol. Oncol. 2015, 37, 68–71. [Google Scholar] [CrossRef]
- Jeha, S.; Chan, K.W.; Aprikyan, A.G.; Hoots, W.K.; Culbert, S.; Zietz, H.; Dale, D.C.; Albitar, M. Spontaneous remission of granulocyte colony-stimulating factor-associated leukemia in a child with severe congenital neutropenia. Blood 2000, 96, 3647–3649. [Google Scholar] [CrossRef] [PubMed]
- Touw, I.P. Game of clones: The genomic evolution of severe congenital neutropenia. Hematol. Am. Soc. Hematol. Educ. Program 2015, 2015, 1–7. [Google Scholar] [CrossRef] [PubMed]
- Ahmed, O.G.; Lambert, E.M. Obstructive sleep apnea in a 5 month old with tonsillar hypertrophy secondary to congenital neutropenia: Case report and literature review. Int. J. Pediatr. Otorhinolaryngol. 2017, 96, 103–105. [Google Scholar] [CrossRef] [PubMed]
- Morikawa, K.; Morikawa, A.; Nakamura, M.; Miyawaki, T. Characterization of granulocyte colony-stimulating factor receptor expressed on human lymphocytes. Br. J. Haematol. 2002, 118, 296–304. [Google Scholar] [CrossRef]
First Admission | First Discharge | Second Admission | Days after Transplantation | Normal Range | ||||
---|---|---|---|---|---|---|---|---|
257 | 600 | 1290 | 1654 | |||||
WBCs (/µL) | 1650 | 1510 | 10,810 | 2950 | 3230 | 5230 | 4920 | 3300–8600 |
Neutrophils (%) | 0.5 | 0 | 0 | 45 | 53 | 58 | 60 | 38.5–81.5 |
Blasts (%) | 10.5 | 4 | 60 | 0 | 0 | 0 | 0 | |
Hb (g/dL) | 6.3 | 7.0 | 7.6 | 9.2 | 12.4 | 12.8 | 12.3 | 11.6–14.8 |
Platelets (/µL) | 151,000 | 412,000 | 57,000 | 208,000 | 201,000 | 204,000 | 219,000 | 158,000–348,000 |
CRP (mg/dL) | 3.45 | 1.73 | 12.0 | 0.05 | 0.07 | 0.02 | 0.01 | 0–0.14 |
G-CSF (pg/dL) | 162 | 121 | <39.0 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Matsumura, R.; Mochizuki, S.; Morishita, Y.; Hayakawa, H.; Karakawa, S.; Kawaguchi, H.; Okada, S.; Hyakuna, N.; Kobayashi, M. Successful Bone Marrow Transplantation in a Patient with Acute Myeloid Leukemia Developed from Severe Congenital Neutropenia Using Modified Chemotherapy and Conditioning Regimen for Leukemia. Hematol. Rep. 2024, 16, 98-105. https://doi.org/10.3390/hematolrep16010010
Matsumura R, Mochizuki S, Morishita Y, Hayakawa H, Karakawa S, Kawaguchi H, Okada S, Hyakuna N, Kobayashi M. Successful Bone Marrow Transplantation in a Patient with Acute Myeloid Leukemia Developed from Severe Congenital Neutropenia Using Modified Chemotherapy and Conditioning Regimen for Leukemia. Hematology Reports. 2024; 16(1):98-105. https://doi.org/10.3390/hematolrep16010010
Chicago/Turabian StyleMatsumura, Risa, Shinji Mochizuki, Yusuke Morishita, Hiroko Hayakawa, Shuhei Karakawa, Hiroshi Kawaguchi, Satoshi Okada, Nobuyuki Hyakuna, and Masao Kobayashi. 2024. "Successful Bone Marrow Transplantation in a Patient with Acute Myeloid Leukemia Developed from Severe Congenital Neutropenia Using Modified Chemotherapy and Conditioning Regimen for Leukemia" Hematology Reports 16, no. 1: 98-105. https://doi.org/10.3390/hematolrep16010010
APA StyleMatsumura, R., Mochizuki, S., Morishita, Y., Hayakawa, H., Karakawa, S., Kawaguchi, H., Okada, S., Hyakuna, N., & Kobayashi, M. (2024). Successful Bone Marrow Transplantation in a Patient with Acute Myeloid Leukemia Developed from Severe Congenital Neutropenia Using Modified Chemotherapy and Conditioning Regimen for Leukemia. Hematology Reports, 16(1), 98-105. https://doi.org/10.3390/hematolrep16010010